51 results
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
with the increased scrutiny relating to environmental, social and governance (ESG) matters ; risks associated with federal, state or foreign health care “fraud
8-K
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
to unfavorable global political or economic events and conditions; risks associated with the increased scrutiny relating to environmental, social and governance
8-K
BTAI
BioXcel Therapeutics Inc
10 Apr 24
Regulation FD Disclosure
7:05am
global political or economic events and conditions; risks associated with the increased scrutiny relating to environmental, social and governance (ESG
8-K
EX-99.1
8u7o 4s5l0mn9
10 Apr 24
Regulation FD Disclosure
7:05am
424B5
8gt7 ew13c6rixrst1ql
25 Mar 24
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
xg6u2986ac69cbaky
12 Mar 24
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
7:15am
8-K
EX-99.1
puhhz99ckn3qir
14 Feb 24
Regulation FD Disclosure
7:00am
424B5
k5zasj6tbhuelipglz5c
8 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
wwvo g07zt3
8 Feb 24
Other Events
4:53pm
8-K
EX-99.1
d1rr3
14 Nov 23
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
cbqwkcl
10 Oct 23
Regulation FD Disclosure
7:06am
8-K
nr55xe68hr450iq4fsz
4 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
ktdcxm1 vu
14 Aug 23
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
7:20am